ORCHID PHARMA LTD.

NSE : ORCHPHARMABSE : 524372ISIN CODE : INE191A01027Industry : Pharmaceuticals & DrugsHouse : Private
BSE929.4044.25 (+5 %)
PREV CLOSE ( ) 885.15
OPEN PRICE ( ) 929.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 145
TODAY'S LOW / HIGH ( )929.40 929.40
52 WK LOW / HIGH ( )18 885.15
NSE907.7043.2 (+5 %)
PREV CLOSE( ) 864.50
OPEN PRICE ( ) 907.70
BID PRICE (QTY) 907.70 (1505)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 43
TODAY'S LOW / HIGH( ) 907.70 907.70
52 WK LOW / HIGH ( )17.15 864.5
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-07 1992
Management Info
Ram Gopal Agarwal - Chairman Manish Dhanuka - Managing Director
Registered Office

Address Orchid Towers,313 , Valluvar Kottam High Road,Nungambakkam,
Chennai,
Tamil Nadu-600034

Phone 044-28211000

Email corporate@orchidpharma.com

Website www.orchidpharma.com

Registrars Details
Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai
Listing : BSE, NSE
NEWS
02Feb Board Meeting Intimation for Notifica
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Direc..
15Jan Orchid Pharma informs about disclosure
In accordance with Regulation 31A(8)(c) of Securities and Exchange Board..
01Jan Orchid Pharma informs about outcome of
Orchid Pharma has informed that the 27th Annual General Meeting (AGM) of..
08Apr Orchid Pharma informs about disclosure
Orchid Pharma has informed that the Exchange has received the disclosure..
06Mar Orchid Pharma informs about appointmen
Orchid Pharma has informed that pursuant to Regulation 30 and other appl..
Financials
Rs. in Millions
QTR Dec 20 ANNUAL 20
Net Profit-453.31-1498.36
Gross Profit -453.31 -1498.36
Operating Profit -38.05-197.76
Net Sales 1026.35054.48
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Alkem Laboratories (BSE)
 2840.00 (4.47%)
M.Cap (Rs. in Cr)33956.46
Abbott India (BSE)
 14514.15 (0.82%)
M.Cap (Rs. in Cr)30841.56
Divis Lab (BSE)
 3462.80 (2.81%)
M.Cap (Rs. in Cr)92170.69
Pfizer (BSE)
 4630.30 (1.75%)
M.Cap (Rs. in Cr)21182.57
Ipca Laboratories (BSE)
 1914.95 (3.55%)
M.Cap (Rs. in Cr)24291.54
Shareholding Pattern
PROMOTERS 98.04%
FI/BANKS/INSURANCE 1.04%
NON-INSTITUTION 0.92%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%
Mf Holdings
Scheme NameHold(%)
GS CNX 500(G)0.01
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Jerina George, Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075,9768009000, E-mail ID: compliance@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.